These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8539919)

  • 41. Combined liver and pancreatic islets transplantation in man using cyclosporin immunosuppression.
    Mazzaferro V; Socci C; Regalia E; Andreola S; Di Bartolomeo M; Bertuzzi F; Di Carlo V; Pozza G; Doci R; Bozzetti F; Gennari L
    Transpl Int; 1994; 7 Suppl 1():S409-11. PubMed ID: 11271266
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sub-therapeutic doses of sirolimus and cyclosporin A in combination reduce SLE pathologies in the MRL mouse.
    Warner LM; Cummons T; Nolan L; Sehgal SN
    Inflamm Res; 1995 Aug; 44 Suppl 2():S205-6. PubMed ID: 8548401
    [No Abstract]   [Full Text] [Related]  

  • 43. Cyclosporine, FK-506, rapamycin, and other immunomodulators.
    Yocum DE
    Rheum Dis Clin North Am; 1996 Feb; 22(1):133-54. PubMed ID: 8907069
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The portal immunosuppressive storm: relevance to islet transplantation?
    Shapiro AM; Gallant HL; Hao EG; Lakey JR; McCready T; Rajotte RV; Yatscoff RW; Kneteman NM
    Ther Drug Monit; 2005 Feb; 27(1):35-7. PubMed ID: 15665744
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunosuppressive properties of FK-506 and rapamycin.
    Thomson AW; Woo J
    Lancet; 1989 Aug; 2(8660):443-4. PubMed ID: 2474733
    [No Abstract]   [Full Text] [Related]  

  • 46. Consensus guidelines for therapeutic drug monitoring of rapamycin: report of the consensus panel.
    Yatscoff RW; Boeckx R; Holt DW; Kahan BD; LeGatt DF; Sehgal S; Soldin SJ; Napoli K; Stiller C
    Ther Drug Monit; 1995 Dec; 17(6):676-80. PubMed ID: 8588240
    [No Abstract]   [Full Text] [Related]  

  • 47. Temporal relationship of insulin, intact proinsulin and split proinsulin after islet autotransplantation.
    White SA; Pollard C; Davies JE; Sutton CD; Hales CN; Dennison AR
    Transplant Proc; 2001; 33(1-2):680. PubMed ID: 11267014
    [No Abstract]   [Full Text] [Related]  

  • 48. Islet toxicity of FK506 measured in canine autografts.
    Ochiai M; Arita S; Nagai T; Sakamoto Y; Smith CV; Shevlin L; Mullen Y
    Transplant Proc; 1998 Mar; 30(2):663. PubMed ID: 9532224
    [No Abstract]   [Full Text] [Related]  

  • 49. The effect of ciclosporin on insulin secretion and resistance.
    Soypacaci Z; Keven K
    Nephrol Dial Transplant; 2007 Nov; 22(11):3358-9; author reply 3359. PubMed ID: 17686811
    [No Abstract]   [Full Text] [Related]  

  • 50. Alternatives to steroids?! Beneficial effects of immunosuppressant drugs in autoimmune pancreatitis.
    Seleznik G; Graf R
    Gut; 2014 Mar; 63(3):376-7. PubMed ID: 23633291
    [No Abstract]   [Full Text] [Related]  

  • 51. Canine islet cell transplantation under the kidney capsule.
    Toledo-Pereyra LH
    Transplantation; 1986 Oct; 42(4):443. PubMed ID: 3094211
    [No Abstract]   [Full Text] [Related]  

  • 52. Rapamycin: Risking Harm for Canine Longevity.
    Abbate C
    Am J Bioeth; 2018 Oct; 18(10):60-61. PubMed ID: 30339072
    [No Abstract]   [Full Text] [Related]  

  • 53. Post-transplant diabetes mellitus. The role of immunosuppression.
    Jindal RM; Sidner RA; Milgrom ML
    Drug Saf; 1997 Apr; 16(4):242-57. PubMed ID: 9113492
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of rapamycin on islet and skin xenograft survival.
    Bobbio SA; Porter JG; Monaco AP
    Transplant Proc; 1993 Aug; 25(4):2745-6. PubMed ID: 8356733
    [No Abstract]   [Full Text] [Related]  

  • 55. FK 506 versus cyclosporine A for steroid-free synergistic combination therapy with rapamycin in a discordant large animal donor xenoislet transplant model.
    Troppmann C; Papalois BE; Gruessner AC; Nakhleh RE; Gruessner RW
    Transplant Proc; 1997; 29(1-2):914-5. PubMed ID: 9123585
    [No Abstract]   [Full Text] [Related]  

  • 56. Immunosuppression for pancreatic islet transplantation.
    Berney T; Buhler LH; Majno P; Mentha G; Morel P
    Transplant Proc; 2004 Mar; 36(2 Suppl):362S-366S. PubMed ID: 15041369
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Beneficial metabolic impact of the novel immunosuppressant rapamycin in chronic canine islet autograft recipients.
    Kneteman NM; Lakey JR; Wagner T; Finegood D
    Transplant Proc; 1995 Dec; 27(6):3213. PubMed ID: 8539919
    [No Abstract]   [Full Text] [Related]  

  • 58. Impact of antipassenger lymphocyte globulin on functional graft survival of discordant xenoislet grafts from a large animal donor.
    Troppmann C; Papalois BE; Gruessner AC; Moon C; Matas AJ; Nakhleh RE; Gruessner RW
    Transplant Proc; 1996 Apr; 28(2):842-4. PubMed ID: 8623429
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.